The immediate reward of neuropathology is to provide the paraplegist with an explanation for the patient's neurological symptoms. This information also assists clinical management by defining the pathology of the bony spine, cord and systemic complications. A detailed knowledge of human spinal cord injury neuropathology also sets the context for basic research. The information on which these studies are based is derived from 191 acute coroner's cases, 95 survivors of spinal cord injury collected since 1958 with the assistance of Sir George Bedbrook, 108 'medical' disorders, 37 others with metastatic carcinoma and 129 normal subjects, giving a total of 560 cases.
tions.
Conventional neuropathology contributes to the clinical management of spinal cord injury (SCI) through its accurate description of the lesions. Thus a know ledge of the exact nature of the disorder in descriptive and temporal terms defines the problem of SCI and assists in the planning of management and of therapeutic interventions. The dynamic neuropathology also provides an essen tial framework for basic research which may be directed toward the develop ment of an 'effective' treatment for SCI in the future.
Within the evolution of the SCI lesions, the primary initiating factors need to be carefully delineated from secondary causes of damage. The effects of pure mechanical injury need to be distinguished from those changes which result from anoxia or impaired perfusion of blood compounded by shock or respiratory problems in an unconscious patient. This approach focuses attention on those factors which determine the tissue injury and which may be amenable to future modification or correction.
It is a truism that a full knowledge of the molecular pathobiology of human SCI is required before any reconstructive interventions, be they physical, phy siological, pharmacological or biological, may be successfully introduced. There fore when the exact molecular circumstances of embryological and fetal growth and development are known there is a possibility that suitable conditions may be re-established for the functional repair of adult SCI in the future. In the broadest molecular terms, it is evident that growth and regeneration genes are switched off in the mature CNS in higher vertebrates as a result of internal regulating processes and/or the influence of external trophic factors. For in stance it is known that the presence of Schwann cells will allow central axonal regeneration to occur (Aguayo et at., 1982a (Aguayo et at., , 1982b . Needless to say, all relevant trophic factors need to be idenified and the ideal embryological conditions re constituted in order to reconstruct new spinal cord tissues. Research in this field is rapidly advancing and a brief review of progress follows.
In our age of recombinant DNA technology the problem can be expressed as follows. 'The cure for SCI is a matter of derepressing the genes responsible for multiplication of neuroblasts, the sprouting of neurites and the regrowth of axons and collaterals with the restoration of physiological connections and functionally useful reflexes by means of guided plasticity and synaptogenes is' .
In the light of recent advances it is not too early to begin to consider how successful reconstruction of the lost segments of the cord may be undertaken.
Even today modification, augmentation and other physiological changes may be induced in spinal patients (Dimitrijevic, 1988) . However, one must be careful not to raise false hopes among the spinally injured. On the other hand it is also necessary to be bold enough to outline the prerequisites for 'curative' neuro logical research. With the advent of recombinant DNA technology a revolution has begun where the very processes of life itself may be influenced and manipul ated. In medicine this revolution does not only apply to the inherited genetic diseases but has equal application to acquired disorders such as SCI. A brief review of the clinical neuropathology and the more applicable recent discoveries in molecular neurobiology now follow.
Neuropathology and experimental neurobiology of SCI

Clinical neuropathology
Some basic neuropathological correlations have been achieved but there is much more to be gained in this respect (Bedbrook and Kakulas, 1968; Kakulas and Bedbrook, 1969, 1976) . In the initial period it is known that spinal shock is responsible for flaccid paralysis which is found initially in most patients. This is the spinal equivalent to cerebral concussion. It is also known that in the following days or weeks neurological recovery is possible to a surprising extent. Hence this CNS tissue is extremely vulnerable to injury. From our neuropath ological observations it is known that in mimy patients there are a large number of axons which survive the initial injury and which remain in continuity follow ing SCI but are in an extremely parlous state.
The precarious blood supply of the spinal cord, dependent as it is on collateral segmental reinforcement, is an additional hazard. A large number of axonal fibres exist that have been temporarily compromised with loss of function but when blood flow returns, bringing oxygen and removing the 'toxic products' of tissue injury, they may recover. The possible detrimental effects of exposure of the cord, the spinal instability resulting from laminectomy, the negative phar macological effects of sedatives, analgesics and anaesthetics and the possibility of further blood loss must all be considered when surgical intervention is being contemplated.
Other clinical neurobiological aspects pertain to the later stages. Many pati ents with SCI experience changes in the subjective awareness of their lower limbs and suffer phantom distortions of body image, pain, burning sensations and other paresthetic phenomena which can be very distressing and interfere with rehabilitation. The morphological correlates of these effects are unknown.
In a few SCI patients there is limited late neurological recovery occurring for reasons which are presently unknown. Whether such late recovery is purely neurophysiological or has a structural basis is a matter of conjecture. Unfortun ately in many other SCI patients late complications may develop. The neuro logical level may rise due to the development of a post traumatic syringomyelia, the growth of nerve roots to the point of becoming a space occupying traumatic neuroma and the progression of degenerative arthritis causing spinal stenosis wih or without vascular insufficiency related to atheroma of the aorta and its segmental branches.
There is a need for quantitative information and some work is in progress. Blight (1983b Blight ( , 1985 also investigated the physiology of SCI in the cat using intracellular electrodes and described delayed demyelination due to macrophage invasion as a secondary phenomenon of cell damage in experimental SCI (Blight, 1985) . Morphometry in experimental SCI in the cat measuring the relation of injury intensity to survival of myelinated axons was also reported (Blight and Decrescito, 1986) . They found the subpial zones to be relatively spared with the larger fibres prone to demyelination. Midha et al. (1987) have investigated the effect of SCI by counting corticospinal and rubrospinal neur ons. For further information the reader is referred to the publications of Balentine (1978) , Das (1983 ), Reier (1985 , Wallace et al. (1987 ), Young (1984 , Young and Flamm (1982) , Young et al. (1981 Young et al. ( , 1982 .
Exploratory treattnents. In general it can be said that many treatments have been tried in the attempt to minimise the effect of SCI and that all of these have been disappointing. Many are based on experimental observations in animals. Some concern the vascular reactions which take place following SCI and others relate to oedema and oxygen supply.
Glucocorticoid mechanisms in acute spinal cord injury were investigated with a review of the therapeutic rationale by Hall and Braughler (1982) . Other treat ments include the effect of oxygen therapy (Jones and Unsworth, 1978; Higgins et al., 1981) and similar work has been undertaken by Yeo (1976) who is a strong advocate of hyperbaric oxygen therapy, his concepts being based on his experimental work in sheep. More recent studies are those of Anderson (1985) who was able to experimentally dissociate hemorrhagic necrosis and loss of axonal conduction. Wallace and Tator report that naloxone fails to improve spinal cord blood flow and cardiac output after SCI, nor does it enhance clinical recovery after experimental injury Tator, 1986a, 1986b) . The effect of calcium blockers has also been assessed with some encouraging results on blood flow (Guha et al., 1987) .
Regeneration and transplantation
In the field of transplantation the works of Aguayo et al. (1982a Aguayo et al. ( , 1982b Aguayo et al. ( , 1984 , Cotman et al. (19R5) , Cotman and Nieto-Sampedro (1985) , Raisman and Ebner (1985) , Lund et al. (1986) and Perez-Polo (1987) are the more prominent. Many other excellent reviews on this topic exist and the reader is referred to the literature for details (Kao, 1974; Reier, 1985) .
Briefly, Aguayo (1982a Aguayo ( , 1982b Aguayo ( , 1984 
PARAPLEGIA
Of particular interest in experimental neurobiology is the recent progress achieved in identifying in trophic factors an era which began with the discovery of nerve growth factor (NGF) by Levi-Monta1cini in 1968 (Levi-Monta1cini et ai., 1975 and pursued by many others. As a result many growth or trophic factors have now been shown to influence the nervous system in addition to NGF. Schwann cell factor, fibroblast and epidermal growth factors and GAP 43 among others, are reported to have biological activity (Aguayo et ai., 1982a (Aguayo et ai., , 1982b (Aguayo et ai., , 1984 . For instance, Kligman and Marschak (1985) have characterised a neurite extension factor from bovine brain. Epidermal growth factor has been found in the CNS and is active in stimulating the growth of neuroblasts in vitro (Fallon et ai., 1984; Gallon et ai., 1984) . It is also known that glia afford a unique 
Discussion and conclusions
Advances in the discovery of trophic factors as definitive organic compounds proceed hand in hand with work on transplantation and regeneration. This work promises to provide information which may eventually be applied to the benefit of patients with SCI. Theoretical considerations in this respect were recently discussed (Kakulas, 1987) . In summary these concepts are as follows.
Hypothetically, if it were possible to restore growth and multiplication of nerve cells and their fibres and create new primary connections using autografts (con verted to primitive neuroblasts), amenable to 're-education' through the prop erty of plasticity then the stage would be reached to seriously consider it possible to 'cure spinal paralysis'. Work along these lines is being conducted by Raisman as recounted by Peter Banyard, editor and research director of the International Spinal Research Trust. He is said to speak of sending genes into the damaged area which have been especially prepared so that they can infiltrate the ap propriate cells. Following this the reconstruction of the complex array of con nections needed for the functioning nervous system is the next step. The princi ple being pursued is the combination of growth genes isolated from cell clones derived from the patient with other genes capable of assuring entry to specific cells in spinal tissue. In this way an encouraging beginning to the problem is underway as described in a simplified manner in the International Spinal Re search Trust newsletter of December 1987. There is room, therefore, for guar ded optimism with regard to the successful outcome of the neurobiological approach to spinal cord injury. The framework having being set by precise studies of the neuropathology of SCI, it is now timely for clinical neuro physiologists to develop methods for augmenting or modifying residual func tions for the benefit of the patient and for the developmental neurobiologists applying the latest techniques of molecular neurobiology in seeking methods of restoration and reconstruction. Thus the first part of this report was devoted to a review of existing neuropathological knowledge followed by a consideration of the theoretical requirements for repair of lost CNS tissues in SCI in the context of cu:-rent neurobiological research. Nevertheless the difficulty of the problems to be encountered should not be trivialised and it would be misleading to belive that a cure for SCI is likely to be found in the foreseeable future.
However it is quite evident that work in this direction has begun in earnest.
